<!DOCTYPE html SYSTEM "about:legacy-compat"><html lang="en-US" data-colors-preset="contrast" data-primary-color="#307FFF"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="UTF-8"><meta name="robots" content="noindex">  <meta name="built-on" content="2024-01-01T12:25:13.3013123"><meta name="build-number" content="${buildNumber}">       <title>复星医药：控股子公司药品ET-26用于成人全身麻醉诱导已于中国境内完成II期临床试验 | 20231016</title><script id="virtual-toc-data" type="application/json">[]</script><script id="topic-shortcuts" type="application/json"></script><link href="https://resources.jetbrains.com/writerside/apidoc/6.6.6-b205/app.css" rel="stylesheet">   <link rel="apple-touch-icon" sizes="180x180" href="https://jetbrains.com/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="https://jetbrains.com/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="https://jetbrains.com/favicon-16x16.png"><link rel="manifest" href="https://jetbrains.com/site.webmanifest"><link rel="mask-icon" href="https://jetbrains.com/safari-pinned-tab.svg" color="#000000"><meta name="msapplication-TileColor" content="#000000"/><meta name="msapplication-TileImage" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-144x144.png"/><meta name="msapplication-square70x70logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-70x70.png"/><meta name="msapplication-square150x150logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-150x150.png"/><meta name="msapplication-wide310x150logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-310x150.png"/><meta name="msapplication-square310x310logo" content="https://resources.jetbrains.com/storage/ui/favicons/mstile-310x310.png"/>  <meta name="image" content=""><!-- Open Graph --><meta property="og:title" content="复星医药：控股子公司药品ET-26用于成人全身麻醉诱导已于中国境内完成II期临床试验 | 20231016"/><meta property="og:description" content=""/><meta property="og:image" content=""/><meta property="og:site_name" content="20231016 Help"/><meta property="og:type" content="website"/><meta property="og:locale" content="en_US"/><meta property="og:url" content="2312.html"/><!-- End Open Graph --><!-- Twitter Card --><meta name="twitter:card" content="summary_large_image"><meta name="twitter:site" content=""><meta name="twitter:title" content="复星医药：控股子公司药品ET-26用于成人全身麻醉诱导已于中国境内完成II期临床试验 | 20231016"><meta name="twitter:description" content=""><meta name="twitter:creator" content=""><meta name="twitter:image:src" content=""><!-- End Twitter Card --><!-- Schema.org WebPage --><script type="application/ld+json"> { "@context": "http://schema.org", "@type": "WebPage", "@id": "2312.html#webpage", "url": "2312.html", "name": "复星医药：控股子公司药品ET-26用于成人全身麻醉诱导已于中国境内完成II期临床试验 | 20231016", "description": "", "image": "", "inLanguage":"en-US" }</script><!-- End Schema.org --><!-- Schema.org WebSite --><script type="application/ld+json"> { "@type": "WebSite", "@id": "/#website", "url": "/", "name": "20231016 Help" }</script><!-- End Schema.org --></head>      <body data-id="2312" data-main-title="复星医药：控股子公司药品ET-26用于成人全身麻醉诱导已于中国境内完成II期临床试验" data-article-props="{&quot;seeAlsoStyle&quot;:&quot;links&quot;}"  data-template="article"  data-breadcrumbs=""  >   <div class="wrapper"><main class="panel _main"><header class="panel__header"><div class="container"><h3>20231016  Help</h3><div class="panel-trigger"></div></div></header><section class="panel__content"><div class="container"><article class="article" data-shortcut-switcher="inactive"><h1 data-toc="2312"   id="2312.md">复星医药：控股子公司药品ET-26用于成人全身麻醉诱导已于中国境内完成II期临床试验</h1>  <p id="184d54a2_15"><span class="control" id="184d54a2_16">界面快报</span></p><p id="184d54a2_17"><span class="control" id="184d54a2_18">2023-10-16 09:31</span></p><p id="184d54a2_19"><span class="control" id="184d54a2_20">https://www.jiemian.com/article/10233822.html</span></p><p id="184d54a2_21">复星医药10月16日公告，控股子公司药品ET-26用于成人全身麻醉诱导已于中国境内完成II期临床试验。该新药是咪唑类静脉全身麻醉药，拟用于全身麻醉的诱导，以及短小外科手术及诊断性检查时的镇静或用于重症监护患者的镇静；同类药物为丙泊酚和依托咪酯。</p><p id="184d54a2_22">该新药用于成人全身麻醉诱导于中国境内将于近日启动III期临床试验。</p><div class="last-modified"> Last modified: 01 一月 2024</div><div data-feedback-placeholder="true"></div><div class="navigation-links _bottom">  <a class="navigation-links__prev" href="2313.html">龙虎榜丨新华制药今日涨停，方新侠席位净买入5507.51万元</a>   <a class="navigation-links__next" href="2307.html">3天2板龙头股份：公司目前经营情况正常，存在换手率高的风险，市净率明显高于同行业水平</a>  </div></article><div id="disqus_thread"></div></div></section></main></div>  <script src="https://resources.jetbrains.com/writerside/apidoc/6.6.6-b205/app.js"></script></body></html>